Revolution Medicines Inc (NAS:RVMD)
$ 59.1 -0.32 (-0.54%) Market Cap: 9.94 Bil Enterprise Value: 8.42 Bil PE Ratio: 0 PB Ratio: 6.08 GF Score: 41/100

Revolution Medicines Inc To Discuss ESMO Data Presentation Call Transcript

Oct 22, 2023 / 04:30PM GMT

Oct 22, 2023 / 04:30PM GMT
Presentation Call
Oct 22, 2023 / 04:30PM GMT

=====================
Corporate Participants
=====================
* Erin Graves
Revolution Medicines, Inc. - Senior Director of Corporate Communications & IR
* Margaret A. Horn
Revolution Medicines, Inc. - COO
* Mark A. Goldsmith
Revolution Medicines, Inc. - CEO, President & Chairman
* Stephen M. Kelsey
Revolution Medicines, Inc. - President of Research & Development
* Wei Lin
Revolution Medicines, Inc. - Chief Medical Officer

=====================
Conference Call Participants
=====================
* Alec Warren Stranahan
BofA Securities, Research Division - Associate
* Ami Fadia
Needham & Company, LLC, Research Division - Senior Analyst
* Benjamin Jay Burnett
Stifel, Nicolaus & Company, Incorporated, Research Division - Associate
* Charles S. Ferranti
Goldman Sachs Group, Inc., Research Division - Research Analyst
* Eric William Joseph
JPMorgan Chase & Co,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot